NCT03551795View on ClinicalTrials.gov

Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 30, 2021

Study Completion Date

March 31, 2022

Conditions
Malignant Solid Tumor
Interventions
BIOLOGICAL

Infusion of iNKT cells

The eligible patients receive twice infusions of iNKT cells(1E8\~1E10) in one course of treatment.

Trial Locations (1)

201508

Shanghai Public Health Clinical Center, Fudan University, Shanghai

All Listed Sponsors
lead

Xiaoyan Zhang

OTHER_GOV

NCT03551795 - Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor | Biotech Hunter | Biotech Hunter